2Marie I,Delafenetre H,Massy N,et al.Tendinous disorders attributed tostatins:a study on ninety-six spontaneous reports in the period 1990-2005and review of the literature〔J〕.Arthritis Rheum,2008;59(3):367-72.
3Jacobson TA.Toward“pain-free”Statin prescribing:clinical algorithm fordiagnosis and management of myalgia〔J〕.Mayo Clin Proc,2008;83(6):687-700.
6Fernandez AB,Kanas RH,Alsheikh-Ali AA,et al.Statins and interstitiallung disease:a systematic review of the literature and of food and drug ad-minstration adverse event reports〔J〕.Chest,2008;134(4):824-30.
7Walker T,McCaffery J,Steinfort C.potential link between HMG-COA re-ductase inhibitor(statin)use and interstitial lung disease〔J〕.MJA,2007;186(2):91-4.
8Ravenskow U,Rosch PJ,Sutter MC,et al.Should we lower cholesterol asmuch as possible〔J〕Br Med J,2006;332(7553):1330-2.
10Baisent C,Blackwell L,Emberson J,et al.Efficacy and safety of moreintensive lowing of LDL cholesterol:a meta analysis of data from170 000 participants in 26 randomised trials〔J〕.Lancet,2010;376(9753):1670-81.
2Chalasani N,Aljadhey H,Kesterson J,et al.Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.Gastroenterology,2004,126:1287-1292.
3Khorashadi S,Hasson NK,Cheung RC.Incidence of statin hepatotoxicity in patients with hepatitis C.Clin Gastroenterol Hepatol,2006,4:902-907.
4de Denus S,Spinler SA,Miller K,et al.Statins and liver toxicity:a meta-analysis.Pharmacotherapy,2004,24:584-591.
5Russo MW,Galanko JA,Shrestha R,et al.Liver transplantation for acute liver failure from drug induced liver injury in the United States.Liver Transpl,2004,10:1018-1023.
